Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia
Clinical trial NCT02997761 · COMPLETED
Trial details
- NCT number
- NCT02997761
- Sponsor
- University of California, Davis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2025-07-17
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.